Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: secondary analysis of the ENCHANTED randomized clinical trial

- Wang, Xia, Robinson, Thompson G., Kim, Jong S., Lavados, Pablo, Lindley, Richard I., Martins, Sheila O., Olavarria, Veronica V., Pandian, Jeyaraj D., Parsons, Mark W., Pontes-Neto, Octavio M., Ricci, Stefano, Sharma, Vijay K., Lee, Tsong-Hai, Li, Qiang, Arima, Hisatomi, Bath, Philip M., Billot, Laurent, Broderick, Joseph, Demchuk, Andrew M., Donnan, Geoffrey

Low-versus standard-dose alteplase in patients on prior antiplatelet therapy: the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

- Robinson, Thompson G., Wang, Xia, Lee, Tsong-Hai, Lindley, Richard I., Martins, Sheila C. O., Olavarria, Veronica V., Pandian, Jeyaraj D., Parsons, Mark W., Pontes-Neto, Octavio M., Ricci, Stefano, Sato, Shoichiro, Sharma, Vijay K., Arima, Hisatomi, Bath, Philip M., Billot, Laurent, Broderick, Joseph P., Demchuk, Andrew M., Donnan, Geoffrey A., Kim, Jong S., Lavados, Pablo M.